These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 22967083)
1. Protein instability and functional defects caused by mutations of dihydro-orotate dehydrogenase in Miller syndrome patients. Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Saito T; Takazaki S; Kanki T; Yamaza H; Nonaka K; Kang D Biosci Rep; 2012 Dec; 32(6):631-9. PubMed ID: 22967083 [TBL] [Abstract][Full Text] [Related]
2. Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH. Rainger J; Bengani H; Campbell L; Anderson E; Sokhi K; Lam W; Riess A; Ansari M; Smithson S; Lees M; Mercer C; McKenzie K; Lengfeld T; Gener Querol B; Branney P; McKay S; Morrison H; Medina B; Robertson M; Kohlhase J; Gordon C; Kirk J; Wieczorek D; Fitzpatrick DR Hum Mol Genet; 2012 Sep; 21(18):3969-83. PubMed ID: 22692683 [TBL] [Abstract][Full Text] [Related]
3. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction. Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Takazaki S; Yamaza H; Nonaka K; Kang D Biosci Rep; 2013 Feb; 33(2):e00021. PubMed ID: 23216091 [TBL] [Abstract][Full Text] [Related]
4. Dihydroorotate dehydrogenase depletion hampers mitochondrial function and osteogenic differentiation in osteoblasts. Fang J; Yamaza H; Uchiumi T; Hoshino Y; Masuda K; Hirofuji Y; Wagener FA; Kang D; Nonaka K Eur J Oral Sci; 2016 Jun; 124(3):241-5. PubMed ID: 27086500 [TBL] [Abstract][Full Text] [Related]
5. Elevated plasma dihydroorotate in Miller syndrome: Biochemical, diagnostic and clinical implications, and treatment with uridine. Duley JA; Henman MG; Carpenter KH; Bamshad MJ; Marshall GA; Ooi CY; Wilcken B; Pinner JR Mol Genet Metab; 2016 Sep; 119(1-2):83-90. PubMed ID: 27370710 [TBL] [Abstract][Full Text] [Related]
6. Miller syndrome with novel dihydroorotate dehydrogenase gene mutations. Kinoshita F; Kondoh T; Komori K; Matsui T; Harada N; Yanai A; Fukuda M; Morifuji K; Matsumoto T Pediatr Int; 2011 Aug; 53(4):587-91. PubMed ID: 21851494 [No Abstract] [Full Text] [Related]
7. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome. Orozco Rodriguez JM; Krupinska E; Wacklin-Knecht H; Knecht W Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1318-1336. PubMed ID: 35094635 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial nucleic acid binding proteins associated with diseases. Uchiumi T; Kang D Front Biosci (Landmark Ed); 2017 Jan; 22(1):168-179. PubMed ID: 27814609 [TBL] [Abstract][Full Text] [Related]
9. Protein-lipid interactions of human dihydroorotate dehydrogenase and three mutants associated with Miller syndrome. Orozco Rodriguez JM; Wacklin-Knecht H; Knecht W Nucleosides Nucleotides Nucleic Acids; 2022; 41(12):1337-1358. PubMed ID: 35184687 [TBL] [Abstract][Full Text] [Related]
10. Extra phenotypic features in a girl with Miller syndrome. Al Kaissi A; Roetzer KM; Ulz P; Heitzer E; Klaushofer K; Grill F Clin Dysmorphol; 2011 Apr; 20(2):66-72. PubMed ID: 21346561 [TBL] [Abstract][Full Text] [Related]
12. Finding disease variants in Mendelian disorders by using sequence data: methods and applications. Ionita-Laza I; Makarov V; Yoon S; Raby B; Buxbaum J; Nicolae DL; Lin X Am J Hum Genet; 2011 Dec; 89(6):701-12. PubMed ID: 22137099 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Martínez-Reyes I; Cardona LR; Kong H; Vasan K; McElroy GS; Werner M; Kihshen H; Reczek CR; Weinberg SE; Gao P; Steinert EM; Piseaux R; Budinger GRS; Chandel NS Nature; 2020 Sep; 585(7824):288-292. PubMed ID: 32641834 [TBL] [Abstract][Full Text] [Related]
14. A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase. Mero IL; Orozco Rodriguez JM; Bjørgo K; Hankin RA; Krupinska E; Kulseth MA; Rossow MA; Knecht W Heliyon; 2024 Oct; 10(19):e38659. PubMed ID: 39430512 [TBL] [Abstract][Full Text] [Related]
15. Preparation of human dihydroorotate dehydrogenase for interaction studies with lipid bilayers. Rodriguez JMO; Krupinska E; Wacklin-Knecht H; Knecht W Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1306-1319. PubMed ID: 31997699 [TBL] [Abstract][Full Text] [Related]
16. Mandibulofacial dysostosis, microtia, and limb anomalies in a newborn: a new form of acrofacial dysostosis syndrome? Zhang Y; Dai Y; Liu Y; Ren J Clin Genet; 2010 Dec; 78(6):570-4. PubMed ID: 20412112 [TBL] [Abstract][Full Text] [Related]
17. Facial dysostoses: Etiology, pathogenesis and management. Trainor PA; Andrews BT Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):283-94. PubMed ID: 24123981 [TBL] [Abstract][Full Text] [Related]
19. Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population. Yang K; Fu LM; Chu XY; Zhang J; Chen WQ; Yan YS; Wang YP; Zhang DL; Yin CH; Guo Q Mol Genet Genomic Med; 2023 Jul; 11(7):e2186. PubMed ID: 37120754 [TBL] [Abstract][Full Text] [Related]
20. Exome sequencing identifies the cause of a mendelian disorder. Ng SB; Buckingham KJ; Lee C; Bigham AW; Tabor HK; Dent KM; Huff CD; Shannon PT; Jabs EW; Nickerson DA; Shendure J; Bamshad MJ Nat Genet; 2010 Jan; 42(1):30-5. PubMed ID: 19915526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]